Can Entresto (sacubitril/valsartan) hurt kidney function?
Entresto can worsen kidney function in some people, but it can also be kidney-protective in others depending on why it’s being used (commonly heart failure). The most important risk is that it can lower blood pressure and reduce kidney blood flow in a way that leads to a rise in creatinine and/or potassium.
In real-world practice, clinicians watch closely for:
- Rising creatinine (a marker of kidney function decline)
- High potassium (hyperkalemia)
- Dehydration/low blood pressure after starting or increasing the dose
Who is most at risk of kidney problems on Entresto?
The risk is higher if you already have factors that make kidney function fragile, such as:
- Chronic kidney disease
- Dehydration or recent vomiting/diarrhea
- Low blood pressure
- Renal artery stenosis (narrowing of kidney arteries)
- Taking other medicines that raise potassium or affect kidney function (for example, certain diuretics or supplements; specific combinations depend on your regimen)
What side effects should patients watch for?
Patients are usually told to get labs and to seek medical advice if they develop signs that could go along with kidney stress, such as:
- Marked weakness, dizziness, or fainting (possible low blood pressure)
- Muscle weakness or palpitations (possible high potassium)
- Little or no urine output, unusual swelling, or sudden shortness of breath
Because kidney injury often has no obvious symptoms early, lab monitoring is the key safeguard.
What do doctors do if kidney numbers rise after starting Entresto?
Clinicians typically respond based on how much creatinine and potassium change and whether you have symptoms. Common adjustments include:
- Slowing or stopping dose increases
- Temporarily holding the medicine during acute illness (like dehydration)
- Adjusting interacting medications
- Correcting dehydration and rechecking kidney labs
A small creatinine rise can happen when kidney blood flow changes; the concern is persistent or significant worsening and/or dangerous potassium levels.
Does Entresto cause chronic kidney damage, or is it usually reversible?
For many patients, early lab changes after starting or increasing Entresto are monitored and managed, and kidney function may stabilize or improve. Persistent kidney injury is more likely when the patient has underlying kidney disease, dehydration, low blood pressure, or problematic drug combinations.
How is Entresto different from ACE inhibitors or ARBs in kidney risk?
Entresto contains an ARB (valsartan) plus a neprilysin inhibitor (sacubitril). ARBs can raise potassium and raise creatinine in some patients. The kidney monitoring approach is similar to other RAAS-blocking drugs, with the same general warning signs (creatinine and potassium).
What patients should do before asking to stay on it
If you have kidney disease or have had prior episodes of “creatinine bump” with blood pressure/heart medications, it’s worth discussing:
- Your baseline creatinine/eGFR and potassium
- How soon you’ll need repeat labs after starting or dose changes
- Which other meds/supplements you’re taking that might increase potassium
- Sick-day rules (what to do if you can’t keep fluids down)
If you share your most recent eGFR/creatinine and potassium levels (and the reason you’re taking Entresto), I can help you interpret what your situation may mean and what monitoring typically looks like.
---
Sources:
None provided with your prompt.